	The relationship between sarcopenia and breast cancer: mechanistic pathways and clinical relevance. Front Cell Dev Biol Wu Y, Cao H, Li M, Hong J, Zhou H, Gao X, Song D. PMID: 42495721 [PubMed - in process]
	Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced thrombocytopenia: exploration and preliminary validation from a multicenter retrospective study. Front Cell Dev Biol Wen Y, Xia J, Dong Y, Liu Z, Yu S, Wang Y, Qing S, Li X, Miao J, Tang D, Yao Y. PMID: 42495717 [PubMed - in process]
	Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial. Cancer Commun (Lond) Wu F, Hu X, Li B, Zhang J, Wang G, Fan H, An G, Yu B, Ma H, Zhao B, Li Z, Gao B, Liu M, Wang X, Liu D, Hu J, Liu H, Liu Y, Wang F, Zhang J, Feng J, Wang X, Meng Z, Zhang Z, Li Z, Sun J, Liu S, Wang N, Han J, Niu W, Zhou C, Xiao L, Wang G. PMID: 42495710 [PubMed - indexed for MEDLINE]
	NUPR1 in breast cancer: mechanisms and potential applications. Front Physiol Xiang B, Liu T, Xu D, Wang W. PMID: 42495706 [PubMed - in process]
	Multidisciplinary Treatment for Esophagogastric Junction Cancer From a Dutch Perspective. Ann Gastroenterol Surg Overtoom HCG, Gisbertz SS. PMID: 42495689 [PubMed - as supplied by publisher]
	Current Status and Challenges of Imaging-Based Diagnosis of Lymph Node Metastasis in Colon Cancer: The Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum. Ann Gastroenterol Surg Ogawa S, Takayama Y, Takamizawa Y, Kanemitsu Y, Ueno H. PMID: 42495688 [PubMed - as supplied by publisher]
	Characteristics of Anal Fistula Cancer in Patients Who Underwent Surgery: A Nationwide Observational Study Using Diagnosis Procedure Combination Data. Ann Gastroenterol Surg Hoshino N, Kinoshita H, Obama K, Fushimi K, Kunisawa S, Imanaka Y. PMID: 42495687 [PubMed - as supplied by publisher]
	Essential Updates 2024-2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization. Ann Gastroenterol Surg Oya S, Yagi K, Baba Y. PMID: 42495683 [PubMed - as supplied by publisher]
	Pylorus-Preserving Gastrectomy for Gastric Cancer: Current Evidence and Future Directions. Ann Gastroenterol Surg Kim SH, Lee HJ. PMID: 42495678 [PubMed - as supplied by publisher]
	Prevalence of MSI-H/dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka-Colorectal Registry. Ann Gastroenterol Surg Morimoto Y, Uemura M, Kagawa Y, Takahashi H, Hiraki M, Suzuki Y, Yoshioka S, Tei M, Okamura S, Mokutani Y, Naito A, Tokuyama S, Komori T, Yasuyama A, Sawada G, Fujie Y, Yamashita S, Haraguchi N, Matsuura Y, Matsuda C, Chinen Y, Shingai T, Danno K, Tanaka N, Sakata K, Murata K, Doki Y, Eguchi H. PMID: 42495674 [PubMed - as supplied by publisher]
	Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives. Ann Gastroenterol Surg El-On R, Kim YW. PMID: 42495673 [PubMed - as supplied by publisher]
	Diagnostic Accuracy of Size-Based Preoperative CT Assessment for Predicting Lymph Node Metastasis in Colon Cancer: A Systematic Review and Meta-Analysis. Ann Gastroenterol Surg Takayama Y, Shimizu T, Watanabe J, Ogawa S, Kanemitsu Y. PMID: 42495671 [PubMed - as supplied by publisher]
	Systematic Review and Meta-Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma. Ann Gastroenterol Surg Sakai M, Kuriyama K, Nagai K, Shirabe K, Saeki H. PMID: 42495669 [PubMed - as supplied by publisher]
	Sex-Based Body Composition Changes in Patients With Rectal Cancer Undergoing Preoperative Chemoradiotherapy: A Prospective Observational Study. Ann Gastroenterol Surg Abe S, Nozawa H, Abe K, Yokota Y, Hori S, Taguchi Y, Yakabe M, Sasaki K, Ogawa S, Ishihara S. PMID: 42495666 [PubMed - as supplied by publisher]
	Exploratory Analysis of Factors Associated With the Recovery of Erectile Dysfunction After Rectal Cancer Surgery (Sub-Analysis of LANDMARC Trial). Ann Gastroenterol Surg Mizuno R, Hida K, Numata M, Sakamoto T, Obama K, Shiomi A, Inada R, Shiozawa M, Ozawa M, Hotchi M, Yamamoto D, Hasegawa S, Miguchi M, Ohnuma S, Yamaguchi T, Akagi T, Kinugasa Y, Yamaguchi S, Kagawa H, Watanabe M, Naitoh T, Takemasa I. PMID: 42495657 [PubMed - as supplied by publisher]
	Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study. Liver Cancer Ueno M, Su YY, Takai A, Huang YH, Morimura H, Nishijima N, Lin SM, Chang CW, Iwamoto S, Nagatomo S, Lai HC, Mitani T, Ikeda A, Uenoyama Y, Umeda M, Chen SC, Chuang CH, Lai SW, Lee TY, Nakano S, Dai CY, Goto T, Su TH, Hsu CS, Lo CC, Takeda H, Osaki Y, Hatano E, Lee PC, Lin PT, Wang HW, Hsu WF, Liu TH, Seno H. PMID: 42495656 [PubMed - as supplied by publisher]
	A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer. Front Immunol Lan J, Sun X, Huang X, Zhao Y, Bi Z, Huang W, Luo T, Jing J, Wu X, Liu L. PMID: 42495649 [PubMed - indexed for MEDLINE]
	RHOA at the intersection of inflammation-driven and sporadic colorectal cancer. Front Immunol Muccioli SE, Hidalgo-García L, Ngo PA, Neurath MF, López-Posadas R. PMID: 42495630 [PubMed - in process]
	Gut microbiota-derived metabolites in gastrointestinal cancer: immunomodulatory mechanisms via the tryptophan-AhR axis and translational perspectives. Front Immunol Xing X, Ying H, Wang DX, Han S. PMID: 42495627 [PubMed - in process]
	Heterogeneity and plasticity of tumor-associated macrophages in oral squamous cell carcinoma: implications for diagnosis and tumor microenvironment characterization. Front Immunol Olmos M, Möst T, Nobis CP, Oetter N, Winter L, Vogl C, Kesting M, Ries J. PMID: 42495621 [PubMed - in process]

Articles 1 - 20 / 1957918

Page 1 of 97896



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy